138 related articles for article (PubMed ID: 1480141)
1. Protection of the ischemic diabetic heart by L-propionylcarnitine therapy.
Paulson DJ; Shug AL; Zhao J
Mol Cell Biochem; 1992 Oct; 116(1-2):131-7. PubMed ID: 1480141
[TBL] [Abstract][Full Text] [Related]
2. Effects of propionyl-carnitine on mitochondrial respiration and post-ischaemic cardiac function in the ischaemic underperfused diabetic rat heart.
Broderick TL; Paulson DJ; Gillis M
Drugs R D; 2004; 5(4):191-201. PubMed ID: 15230624
[TBL] [Abstract][Full Text] [Related]
3. L-propionylcarnitine and myocardial performance in stunned porcine myocardium.
Sassen LM; Duncker DJ; Hogendoorn A; McFalls EO; Krams R; Bezstarosti K; Lamers JM; Verdouw PD
Mol Cell Biochem; 1992 Oct; 116(1-2):147-53. PubMed ID: 1480143
[TBL] [Abstract][Full Text] [Related]
4. Carnitine supplementation improves myocardial function in hearts from ischemic diabetic and euglycemic rats.
Keller VA; Toporoff B; Raziano RM; Pigott JD; Mills NL
Ann Thorac Surg; 1998 Nov; 66(5):1600-3. PubMed ID: 9875758
[TBL] [Abstract][Full Text] [Related]
5. Control of the cardiac consequences of myocardial ischemia and reperfusion by L-propionylcarnitine: age-response and dose-response studies in the rat heart.
Riva E; Leopaldi D
Pediatr Res; 1993 Oct; 34(4):465-70. PubMed ID: 8255679
[TBL] [Abstract][Full Text] [Related]
6. L-propionylcarnitine enhancement of substrate oxidation and mitochondrial respiration in the diabetic rat heart.
Broderick TL; Haloftis G; Paulson DJ
J Mol Cell Cardiol; 1996 Feb; 28(2):331-40. PubMed ID: 8729065
[TBL] [Abstract][Full Text] [Related]
7. The blood contribution to early myocardial reperfusion injury is amplified in diabetes.
McDonagh PF; Hokama JY; Copeland JG; Reynolds JM
Diabetes; 1997 Nov; 46(11):1859-67. PubMed ID: 9356037
[TBL] [Abstract][Full Text] [Related]
8. Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat.
Broderick TL; Driedzic W; Paulson DJ
Mol Cell Biochem; 2000 Mar; 206(1-2):151-7. PubMed ID: 10839205
[TBL] [Abstract][Full Text] [Related]
9. Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris.
Bartels GL; Remme WJ; Pillay M; Schönfeld DH; Kruijssen DA
Am J Cardiol; 1994 Jul; 74(2):125-30. PubMed ID: 8023775
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury.
Sloan RC; Moukdar F; Frasier CR; Patel HD; Bostian PA; Lust RM; Brown DA
J Mol Cell Cardiol; 2012 May; 52(5):1009-18. PubMed ID: 22406429
[TBL] [Abstract][Full Text] [Related]
11. Protection of the reperfused heart by L-propionylcarnitine.
Leipälä JA; Bhatnagar R; Pineda E; Najibi S; Massoumi K; Packer L
J Appl Physiol (1985); 1991 Oct; 71(4):1518-22. PubMed ID: 1757378
[TBL] [Abstract][Full Text] [Related]
12. Effects of Nitrate Intake on Myocardial Ischemia-Reperfusion Injury in Diabetic Rats.
Jeddi S; Khalifi S; Ghanbari M; Bageripour F; Ghasemi A
Arq Bras Cardiol; 2016 Oct; 107(4):339-347. PubMed ID: 27849257
[TBL] [Abstract][Full Text] [Related]
13. The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts.
Tosaki A; Engelman DT; Engelman RM; Das DK
Cardiovasc Res; 1996 Apr; 31(4):526-36. PubMed ID: 8689644
[TBL] [Abstract][Full Text] [Related]
14. Role of myocardial nitric oxide in diabetic ischemia-reperfusion dysfunction: studies in mice with myocyte-specific overexpression of endothelial nitric-oxide synthase.
Pozo-Navas B; Stessel H; Wölkart G; Brunner F
J Pharmacol Exp Ther; 2006 Nov; 319(2):729-38. PubMed ID: 16857730
[TBL] [Abstract][Full Text] [Related]
15. Effects of endogenous and exogenous lysophosphatidylcholine in isolated perfused rat hearts.
Sargent CA; Vesterqvist O; Ogletree ML; Grover GJ
J Mol Cell Cardiol; 1993 Aug; 25(8):905-13. PubMed ID: 8263961
[TBL] [Abstract][Full Text] [Related]
16. Relative importance of enhanced glucose uptake versus attenuation of long-chain acyl carnitines in protecting ischemic myocardium.
Hwang YC; Bakr S; Ramasamy R; Bergmann SR
Coron Artery Dis; 2002 Sep; 13(6):313-8. PubMed ID: 12436025
[TBL] [Abstract][Full Text] [Related]
17. Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin.
Bayrami G; Karimi P; Agha-Hosseini F; Feyzizadeh S; Badalzadeh R
J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):174-183. PubMed ID: 28901167
[TBL] [Abstract][Full Text] [Related]
18. L-carnitine increases glucose metabolism and mechanical function following ischaemia in diabetic rat heart.
Broderick TL; Quinney HA; Lopaschuk GD
Cardiovasc Res; 1995 Mar; 29(3):373-8. PubMed ID: 7781011
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cardioprotective efficacy resulting from a combination of atorvastatin and ischaemic post-conditioning in diabetic and non-diabetic rats.
Fan Y; Yang S; Zhang X; Cao Y; Huang Y
Clin Exp Pharmacol Physiol; 2012 Nov; 39(11):938-43. PubMed ID: 23106693
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of GSK-3β and reduction of apoptosis as targets of troxerutin effect on reperfusion injury of diabetic myocardium.
Mokhtari B; Badalzadeh R; Alihemmati A; Mohammadi M
Eur J Pharmacol; 2015 Oct; 765():316-21. PubMed ID: 26341011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
